PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.82%
Some net income increase while AVGO is negative at -7.76%. John Neff would see a short-term edge over the struggling competitor.
6.76%
Some D&A expansion while AVGO is negative at -9.01%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-550.00%
Negative yoy deferred tax while AVGO stands at 44.85%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
6.73%
Less SBC growth vs. AVGO's 31.20%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
40.90%
Well above AVGO's 70.91% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-538.89%
AR is negative yoy while AVGO is 167.03%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
16.95%
Some inventory rise while AVGO is negative at -50.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
159.68%
A yoy AP increase while AVGO is negative at -42.50%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
71.68%
Some yoy usage while AVGO is negative at -0.80%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-177.42%
Negative yoy while AVGO is 871.43%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
20.60%
Operating cash flow growth above 1.5x AVGO's 11.55%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-47.25%
Both yoy lines negative, with AVGO at -18.45%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-34.32%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-23.87%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
1150.00%
Growth of 1150.00% while AVGO is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-8617.86%
Both yoy lines negative, with AVGO at -208.74%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
64.21%
Debt repayment at 50-75% of AVGO's 100.00%. Martin Whitman would worry about partial lag if competitor gains advantage from lower debt burdens.
-23.53%
Negative yoy issuance while AVGO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
23.30%
We have some buyback growth while AVGO is negative at -124.85%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.